Simris Group
0.126 SEK +6.33%Be the first to follow this company
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Read moreRevenue
4.35M
EBIT %
-842.3 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SIMRIS B
Daily low / high price
0.115 / 0.126
SEK
Market cap
43.86M SEK
Turnover
38.6K SEK
Volume
315K
Financial calendar
Interim report
2024-05-15
General meeting
2024-05-29
Interim report
2024-08-14
Interim report
2024-11-13
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7.1 % | 7.1 % |
SIX SIS AG, W8IMY | 5.3 % | 5.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2023
SIMRIS GROUP CONFIRMS A TERM EXTENSION TO FLEXIBLE FUNDING FACILITY
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools